Comments

TransCode Therapeutics

Q: What sector and industry does TransCode Therapeutics (RNAZ) operate in?

TransCode Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

RNAZNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$0.367600

0.025.06%

Pre-Market: 7:04 PM EDT

TransCode Therapeutics (RNAZ) Forecast

News Earnings TransCode Therapeutics (RNAZ) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Overview Rating

Speculative

Technicals Analysis

0100

Financials Analysis

0100

TransCode Therapeutics (NASDAQ:RNAZ) Stock Quotes, Forecast and News Summary

TransCode Therapeutics Stock (NASDAQ: RNAZ) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	14.00 / 1.67M
Day Range	- - -
52 Wk Range	0.22 - 18.66
Market Cap	$6.35M
P/E Ratio	0.00
Dividend Yield	-
Exchange	NASDAQ
RSI	36
Short Interest	4.31%
Days to Cover	1

Recent News

Why Pitney Bowes Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Gold Moves Higher; Coca-Cola Increases FY24 Forecast

Avi Kapoor

Why Transcode Therapeutics (RNAZ) Stock Is Down 60%

Transcode Therapeutics shares are trading lower by 62% during Tuesday's session. The company announced pricing of its public offering.

Henry Khederian

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

May

Aug

Sep

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	14.00 / 1.67M
Day Range	- - -
52 Wk Range	0.22 - 18.66
Market Cap	$6.35M
P/E Ratio	0.00
Dividend Yield	-
Exchange	NASDAQ
RSI	36
Short Interest	4.31%
Days to Cover	1

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy TransCode Therapeutics (RNAZ) stock?

You can purchase shares of TransCode Therapeutics (NASDAQ:RNAZ) through any online brokerage.

View our list of the best stock brokerages

Who are TransCode Therapeutics (RNAZ) competitors?

Other companies in TransCode Therapeutics’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Eterna Therapeutics (NASDAQ:ERNA), Alzamend Neuro (NASDAQ:ALZN), Coeptis Therapeutics (NASDAQ:COEP) and ABVC BioPharma (NASDAQ:ABVC).

What is the forecast, or price target, for TransCode Therapeutics (RNAZ) stock?

TransCode Therapeutics has a consensus price target of $3.00.

What is the current price for TransCode Therapeutics (RNAZ)?

The stock price for TransCode Therapeutics (NASDAQ: RNAZ) is $0.3676 last updated November 14, 2024 at 7:04 PM EST.

Does TransCode Therapeutics (RNAZ) pay a dividend?

There are no upcoming dividends for TransCode Therapeutics.

When is TransCode Therapeutics (NASDAQ:RNAZ) reporting earnings?

TransCode Therapeutics’s Q3 earnings are confirmed for Tuesday, November 26, 2024.

Is TransCode Therapeutics (RNAZ) going to split?

There is no upcoming split for TransCode Therapeutics.

What sector and industry does TransCode Therapeutics (RNAZ) operate in?

TransCode Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.